Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> WHO Names New Leadership Team 03/10/2017 William New The World Health Organization today announced the new leadership team for the UN agency, with a range of geographic representation and a majority of women in the top posts. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 Catherine Saez The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> WHO Names New Leadership Team 03/10/2017 William New The World Health Organization today announced the new leadership team for the UN agency, with a range of geographic representation and a majority of women in the top posts. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 Catherine Saez The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> WHO Names New Leadership Team 03/10/2017 William New The World Health Organization today announced the new leadership team for the UN agency, with a range of geographic representation and a majority of women in the top posts. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 Catherine Saez The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
WHO Names New Leadership Team 03/10/2017 William New The World Health Organization today announced the new leadership team for the UN agency, with a range of geographic representation and a majority of women in the top posts. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 Catherine Saez The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 Catherine Saez The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 Catherine Saez The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts
Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Posts navigation Older postsNewer posts